semaglutide and alzheimer's Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment Ozempic linked to lower Alzheimer's

GLP-1 receptors are distributed across the hypothalamus, brainstem, reward centers, and memory regions, influencing hunger signals, food preferences, and potentially cognitive function

GHK-Cu accelerates the collagen remodeling the treatment is designed to trigger

Lancet 402 , 203234 (2023)

These groundbreaking medications, initially approved for patients with type 2 diabetes, are now revolutionizing chronic disease treatment through their metabolic, hormonal, and anti-inflammatory effects, becoming vital tools in addressing conditions like cardiovascular disease, nonalcoholic fatty liver disease, osteoarthritis, and more

Do not touch the cleaned area with your hands until after youve completed the injection

C.IngbarS